Dr. Reddy's Laboratories Limited (ADR) (NYSE:RDY)
CAPS Rating:
A global pharmaceutical company, which produces pharmaceutical ingredients and intermediates, finished dosage forms and biotechnology products and markets them globally. It conducts research in the areas of cancer, diabetes, cardiovascular disease etc.
RSS Headlines
Fool UK
Recs
Hidden under the shadow of India's current money woes, Dr.Reddy is now a global generic company with superlative service creds. The domestic market alone insures they'll profit [1.2 billion consumers]. They have lots of little partnerships with companies large and small - and, if they like what a small company is doing well enougn, they have the cash flow to buy it.